Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2022-06-30 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document text explicitly states: 'PureTech Health plc Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company share repurchases.
2022-06-30 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of ordinary shares by PureTech Health PLC as part of its Share Buyback Programme, providing specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Share Repurchase/Issuance), which maps to the filing code POS. The RNS Number format confirms it is a regulatory announcement, but the content is specific enough to use the more precise code.
2022-06-29 English
PRTC's Vedanta Unveils New Manufacturing Facility
Regulatory Filings Classification · 100% confidence The document is distributed via RNS (RNS Number : 3767Q) and contains a press release format announcing news about a subsidiary (Vedanta Biosciences) opening a new manufacturing facility. The announcement is dated June 28, 2022, and is issued by PureTech Health PLC. This type of general corporate news release, especially one distributed through the RNS system and not fitting into specific financial reporting categories (like 10-K, ER, or DIV), is best classified as a general Regulatory Filing or Announcement. Since it is a standard press release distributed via the RNS service, the most appropriate classification is RNS, which serves as the general regulatory announcement fallback.
2022-06-28 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The RNS Number format (3571Q) and the date (28 June 2022) confirm it is a regulatory announcement regarding a corporate action.
2022-06-28 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2022-06-27 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document text explicitly states it is an announcement regarding a 'Transaction in Own Shares' as part of a 'Share Buyback Programme'. It details the date of purchase, number of shares purchased, and the price range. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). Although it is filed via RNS (indicated by 'RNS Number'), the specific corporate action described (share repurchase) takes precedence over the general regulatory filing category.
2022-06-24 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.